Related Experiment Videos
New prognostic factors in oncology
A Sgambato1, G Flamini, A Cittadini
1Centro di Ricerche Oncologiche Giovanni XXIII, Università Cattolica del S. Cuore, Policlinico A. Gemelli, Roma, Italy.
Rays
|October 1, 1996
Summary
Reliable prognostic factors in cancer are crucial, sometimes outweighing therapy. Advances in biological, cellular, and molecular information aid in identifying key cancer genes and cell kinetics for better clinical oncology outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Cellular Biology
Background:
- Prognostic factors are vital in oncology, often proving more critical than treatment.
- Current advancements in biological, cellular, and molecular information offer new insights.
Purpose of the Study:
- To examine the role of biological, cellular, and molecular factors in cancer prognosis.
- To evaluate the clinical relevance of these prognostic factors in oncology.
Main Methods:
- Identification of oncogenes and tumor suppressor genes (TSG) alterations (hyperexpression, mutation, deletion).
- Analysis of cell kinetics parameters in neoplastic tissue, including DNA index and S-phase fraction.
- Evaluation of examined factors in clinical oncology through case instances.
Main Results:
- Discovered that specific oncogene and tumor suppressor gene alterations significantly impact cancer prognosis.
- Demonstrated the prognostic value of cell kinetics parameters like DNA index and S-phase.
- Highlighted the clinical applicability of these molecular and kinetic factors in patient management.
Conclusions:
- Reliable prognostic factors, especially molecular and kinetic ones, are indispensable in modern oncology.
- These factors provide valuable information that can guide therapeutic decisions and improve patient outcomes.
- Continued research into biological, cellular, and molecular markers will further refine cancer prognosis and treatment.